Reid Hoffman's Manas AI raises $24.6M, a fraction of other AI drug discovery startups | TechCrunchManas AI, co-founded by Reid Hoffman, is an AI-driven startup focusing on drug discovery for major cancers, raising $24.6 million in seed funding.
Europe accelerates AI drug discovery as DeepMind spinoff targets trials this yearIsomorphic Labs aims to start clinical trials for AI-designed drugs by the end of this year.
Formation Bio raises $372M to boost drug development with AI | TechCrunchFormation Bio raised $372 million in Series D funding round led by Andreessen Horowitz, totaling $528 million, focusing on AI drug discovery and partnerships.
Europe accelerates AI drug discovery as DeepMind spinoff targets trials this yearIsomorphic Labs aims to start clinical trials for AI-designed drugs by the end of this year.
Formation Bio raises $372M to boost drug development with AI | TechCrunchFormation Bio raised $372 million in Series D funding round led by Andreessen Horowitz, totaling $528 million, focusing on AI drug discovery and partnerships.